Neurodermatitis
Showing 1 - 25 of 123
Groin Infection, Neurodermatitis, Psoriasis Trial in Changchun (The novel electrolyzed water spray)
Recruiting
- Groin Infection
- +3 more
- The novel electrolyzed water spray
-
Changchun, Jilin, ChinaChangchun Jiahe Surgery Hospital
Mar 17, 2023
Prurigo Nodularis Trial (Dupilumab SAR231893 (REGN668))
Not yet recruiting
- Prurigo Nodularis
- Dupilumab SAR231893 (REGN668)
- (no location specified)
Oct 11, 2023
Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)
Not yet recruiting
- Prurigo Nodularis
- Ruxolitinib Cream
- Vehicle Cream
- (no location specified)
Mar 1, 2023
Lichen Simplex Chronicus Trial in Bensheim, Berlin (drug, diagnostic test, procedure, other)
Recruiting
- Lichen Simplex Chronicus
- IMP Application KM-001
- +12 more
-
Bensheim, Germany
- +1 more
Jul 7, 2022
Dermatitis, Atopic, Eczema, Atopic, Neurodermatitis, Atopic Trial in Germany (Secukinumab 300 mg, Placebo)
Completed
- Dermatitis, Atopic
- +2 more
- Secukinumab 300 mg
- Placebo
-
Dresden, Germany
- +4 more
Apr 30, 2021
Prurigo Nodularis Trial in Germany, United States (CDX-0159, Normal saline)
Recruiting
- Prurigo Nodularis
- CDX-0159
- Normal saline
-
Tempe, Arizona
- +18 more
Jan 4, 2023
Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis,
Unknown status
- Prurigo Nodularis
- Atopic Dermatitis
- Skin biopsy
- Plastic surgery remnants
- (no location specified)
Feb 6, 2021
Keloid, Alopecia Areata, Acne Trial in Nashville (Corticosteroid with lidocaine, Corticosteroid with normal saline)
Completed
- Keloid
- +14 more
- Corticosteroid with lidocaine
- Corticosteroid with normal saline
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 18, 2021
Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Münster (nalbuphine HCl ER)
Completed
- Prurigo Nodularis
- +2 more
- nalbuphine HCl ER
-
Münster, GermanyUniversity of Münster
Oct 5, 2020
Prurigo Nodularis Trial in Germany (serlopitant, Placebo)
Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)
Completed
- Neurodermatitis
- Dupilumab SAR231893
- +4 more
-
Gilbert, Arizona
- +62 more
Nov 11, 2022
Chronic Idiopathic Urticaria, Chronic Idiopathic Pruritus, Lichen Planus Trial in United States (KPL-716, Placebo)
Completed
- Chronic Idiopathic Urticaria
- +4 more
- KPL-716
- Placebo
-
Anniston, Alabama
- +18 more
Nov 29, 2021
Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Germany, Poland, United States (nalbuphine HCl ER tablets 90 mg BID,
Completed
- Prurigo Nodularis
- +3 more
- nalbuphine HCl ER tablets 90 mg BID
- +2 more
-
Cleveland, Ohio
- +3 more
Oct 5, 2020
Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)
Completed
- Neurodermatitis
- Dupilumab SAR231893
- +4 more
-
Fort Smith, Arkansas
- +56 more
Dec 2, 2021
Prurigo Nodularis, Pruritis Trial in Worldwide (vixarelimab, Placebo)
Active, not recruiting
- Prurigo Nodularis
- Pruritis
- vixarelimab
- Placebo
-
Anniston, Alabama
- +76 more
Jan 3, 2023
Pruritus, Prurigo Nodularis Trial in Austria, Germany, Poland (5mg Serlopitant Tablets, Placebo Tablets)
Completed
- Pruritus
- Prurigo Nodularis
- 5mg Serlopitant Tablets
- Placebo Tablets
-
Graz, Austria
- +39 more
May 18, 2021
Lichen Sclerosus, Lichen Planus, Lichen Simplex Chronicus Trial in Zagreb ("Three Rings Vulvoscopy" (TRIV), Histopathology)
Completed
- Lichen Sclerosus
- +3 more
- "Three Rings Vulvoscopy" (TRIV)
- Histopathology
-
Zagreb, CroatiaPoliklinika Harni
Oct 7, 2019
Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)
Completed
- Pruritus
- Prurigo Nodularis
- 5mg Serlopitant Tablets
- Placebo Tablets
-
Birmingham, Alabama
- +48 more
May 18, 2021
Prurigo Nodularis Trial in Worldwide (Nemolizumab 30 mg, Placebo)
Recruiting
- Prurigo Nodularis
- Nemolizumab 30 mg
- Placebo
-
Birmingham, Alabama
- +109 more
Jun 29, 2022
HIV, HIV-1 Trial in Worldwide (Etravirine)
Active, not recruiting
- HIV Infections
- HIV-1
-
Los Angeles, California
- +30 more
Jan 17, 2023
Prurigo Nodularis Trial in Hellerup (Apremilast Oral Product)
Unknown status
- Prurigo Nodularis
- Apremilast Oral Product
-
Hellerup, DenmarkDepartment of Dermato-Allergology
Jul 2, 2018
